DOD issues notice of a TRICARE OTC project

The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies

The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.

Brian Nowosielski;Marta Wosinska, PhD;Joey Mattingly, PharmD, MBA, PhD

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Ashley Gallagher

Scripted for Her: Addressing Preconception Health Through MTM

Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.

Killian Meara;Natalie DiPietro Mager, PharmD, PhD;David Bright, PharmD, MBA

June 9th 2025

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Kathryn Wheeler, PharmD, BCPS

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.

Bob Kronemyer

FDA Approves Mavyret for Treatment of Acute HCV Infection

Direct-to-consumer drug sales may undermine patient care and threaten independent pharmacies by reducing access to personalized, comprehensive medication management.

Related Content

Killian Meara

The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies

The therapy is the first and only oral direct acting antiviral approved by the FDA for HCV infection.

Brian Nowosielski;Marta Wosinska, PhD;Joey Mattingly, PharmD, MBA, PhD

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Ashley Gallagher

Scripted for Her: Addressing Preconception Health Through MTM

Investigators find that patients with moderate weight loss or those who were weight resistant still had improvement in cardiometabolic health.

Killian Meara;Natalie DiPietro Mager, PharmD, PhD;David Bright, PharmD, MBA

June 9th 2025

First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract Infection

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Kathryn Wheeler, PharmD, BCPS

Direct-to-Consumer Pharmacies: Why Skipping the Counter Puts Patients at Risk

This novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.

Bob Kronemyer